Fetal Exposure From Placental pH Gradients

Why Maternal-Fetal pH Matters

A drug can cross the placenta in its neutral form while charged forms cross much less readily. Because maternal and fetal blood may have different pH values, the same weak acid or base can have different ionized fractions on the two sides. This can produce a difference in unbound total concentration even when the neutral species has equilibrated. The direction and size of that difference depend on whether the drug is an acid or a base, its pKa, and the pH values.

The useful prediction is conditional: it describes the equilibrium implied by a simplified passive-partition model, not a general guarantee about fetal exposure at every time. It also does not mean that a concentration difference necessarily represents ongoing net transfer. For example, the neutral species may have equal concentrations on both sides even though the sums of neutral and ionized unbound species differ.

Species Fractions and the Equilibrium Prediction

Consider a monoprotic weak acid, \(HA\), which dissociates as \(HA \rightleftharpoons H^+ + A^-\). The Henderson-Hasselbalch relationship gives the ratio of ionized to neutral concentration as \([A^-]/[HA]=10^{\mathrm{pH}-\mathrm{p}K_a}\). Therefore, at a specified pH, the unbound total concentration divided by the neutral concentration is \(1+10^{\mathrm{pH}-\mathrm{p}K_a}\).

For a monoprotic weak base, write the neutral form as \(B\) and the protonated, charged form as \(BH^+\). Since \([BH^+]/[B]=10^{\mathrm{p}K_a-\mathrm{pH}}\), its unbound total concentration is \( [B]\left(1+10^{\mathrm{p}K_a-\mathrm{pH}}\right)\). These expressions assume that the stated pH and pKa describe the relevant aqueous conditions and that concentrations can be used in the Henderson-Hasselbalch relationship.

Suppose neutral drug passively crosses the placenta and has reached equilibrium between maternal and fetal aqueous compartments. In the simplified model, neutral concentration is then equal on both sides. Dividing the fetal unbound total concentration by the maternal unbound total concentration cancels that common neutral concentration. The resulting ratios are the pH-partition predictions:

Here \(F\) and \(M\) denote fetal and maternal compartments, and \(C_u\) denotes unbound total concentration. If fetal pH is lower than maternal pH, ionization of a weak acid is less favored in the fetus, so its predicted unbound total ratio is below one. Protonation of a weak base is more favored in the fetus, so its ratio is above one. These directional statements follow from the equations, but the size of the effect depends on pKa and the pH difference.

Worked Calculations

Derivation, Assumptions, and Interpretation

The ratio formula follows directly from the species relationships, rather than from a special placental transport rule. For an acid, write the fetal and maternal unbound totals as the neutral concentration in each compartment multiplied by its pH-dependent factor. Under neutral equilibrium, those neutral concentrations are equal. Cancelling them leaves the acid ratio above. For a base, the same cancellation applies with the base’s protonation factor. The derivation is summarized here.

The assumptions matter. The model treats the drug as a monoprotic acid or base with a known pKa, uses the pH of the relevant aqueous compartments, and assumes passive transfer of the neutral species until its concentration equilibrates. It also assumes that ionized-species passage, active transport, metabolism during transfer, and other departures from this simple partition are negligible for the prediction. If pH changes over time, the calculated ratio changes as well. A ratio calculated from one pair of pH values is not automatically applicable at every gestational age or exposure time.

The earlier material on bidirectional placental transfer equations provides a framework for describing exchange across the placenta. The pH-partition calculation adds a species-specific equilibrium interpretation; it does not replace a time-dependent transfer model when the system has not equilibrated. Nor does a predicted ratio establish the rate at which equilibrium is approached.

When a Concentration Gradient Misleads

An unbound total gradient and a neutral-species gradient answer different questions. At the model’s equilibrium, neutral concentrations can be equal while unbound totals differ because the ionized fractions differ. Thus, observing or predicting \(C_{u,F}/C_{u,M}\ne 1\) does not, by itself, show a remaining neutral-species driving gradient or ongoing net passive transfer.

A measured total concentration adds another layer. If total concentration includes bound drug and the unbound fractions differ between maternal and fetal samples, then:

This relation is an accounting identity when \(f_u=C_u/C_{\mathrm{total}}\) is defined consistently for both samples. It shows why total ratios may exaggerate, reduce, or even reverse the apparent unbound gradient. Interpretation also depends on what the assay measures: a reported total concentration should not be treated as an unbound aqueous concentration unless that is what was measured.

Useful checks include confirming whether pH and pKa use compatible conditions, verifying that the acid or base equation has been selected correctly, and stating whether a reported value is unbound or total. A ratio far from one should prompt a review of exponent signs and compartment labels. For example, putting fetal pH in the maternal denominator changes the question. A prediction should also be treated cautiously when its assumptions are implausible, such as when appreciable charged-species transport or active transport is known to matter.

Common Mistakes and Limitations

• Reversing the acid and base relationships. For an acid, the ionized-to-neutral ratio is \(10^{\mathrm{pH}-\mathrm{p}K_a}\); for a base, the protonated-to-neutral ratio is \(10^{\mathrm{p}K_a-\mathrm{pH}}\). Check the species and exponent before calculating.
• Omitting the neutral contribution. The unbound total factor is \(1+\) the ionized-to-neutral ratio, not the ratio alone. The neutral species remains part of the total.
• Calling a total gradient proof of net transfer. A total or unbound-total ratio does not by itself establish a neutral-species gradient or the direction of instantaneous net flux.
• Ignoring binding when interpreting measured totals. If unbound fractions differ, a total ratio is not the same as the unbound ratio.
• Treating equilibrium as an instantaneous prediction. The equations do not describe how quickly concentrations approach the predicted relationship or the full time course after dosing.

The pH-partition approach is a focused equilibrium calculation, not a complete fetal exposure model. Its predictions can be inaccurate if the relevant pH values are unknown or variable, the drug has multiple ionizable groups, the neutral species is not the only species that crosses, or binding and transport processes depart from the assumptions. It is most useful as a transparent mechanistic benchmark: it predicts the direction and approximate size of an ionization-driven unbound gradient before other processes are added.